Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
793,884
-
Shares change
-
+223,166
-
Total reported value, excl. options
-
$129,353,080
-
Value change
-
+$36,441,945
-
Put/Call ratio
-
46%
-
Number of buys
-
52
-
Number of sells
-
-22
-
Price
-
$162.93
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2020
111 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2020.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 793,884 shares
.
Largest 10 shareholders include Pinnacle Advisory Group, Inc. (118,881 shares), MORGAN STANLEY (67,205 shares), ROYAL BANK OF CANADA (61,644 shares), GOLDMAN SACHS GROUP INC (50,000 shares), UBS Group AG (41,984 shares), BANK OF AMERICA CORP /DE/ (34,950 shares), MURPHY CAPITAL MANAGEMENT INC (34,068 shares), LPL Financial LLC (31,144 shares), MOGY JOEL R INVESTMENT COUNSEL INC (24,370 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (19,510 shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.